The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis
Open accessAbstract
Pulmonary fibrosis is the consequence of a variety of diseases with no satisfying treatment option. Therapy-induced fibrosis also limits the efficacy of chemotherapy and radiotherapy in numerous cancers. Here, we studied the potential of platelet-derived growth factor (PDGF) receptor tyrosine kinase inhibitors (RTKIs) to attenuate radiation-induced pulmonary fibrosis. Thoraces of C57BL/6 mice were irradiated (20 Gy), and mice were treated with three distinct PDGF RTKIs (SU9518, SU11657, or Imatinib). Irradiation was found to induce severe lung fibrosis resulting in dramatically reduced mouse survival. Treatment with PDGF RTKIs markedly attenuated the development of pulmonary fibrosis in excellent correlation with clinical, histological, and computed tomography results. Importantly, RTKIs also prolonged the life span of irradiated mice. We found that radiation up-regulated expression of PDGF (A–D) isoforms leading to phosphorylation of PDGF receptor, which was strongly inhibited by RTKIs. Our findings suggest a pivotal role of PDGF signaling in the pathogenesis of pulmonary fibrosis and indicate that inhibition of fibrogenesis, rather than inflammation, is critical to antifibrotic treatment. This study points the way to a potential new approach for treating idiopathic or therapy-related forms of lung fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
The Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,409
Transforming Growth Factor β in Tissue Fibrosis
Epstein, F. H., Border, W. A., & Noble, N. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311907 · Cited by 3,069
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
Bergers, G., Song, S., Meyer-Morse, N., Bergsland, E., & Hanahan, D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17929 · Cited by 1,370
Idiopathic Pulmonary Fibrosis: Clinical Relevance of Pathologic Classification
KATZENSTEIN, A.-L. A., & MYERS, J. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707039 · Cited by 1,261
Gross, T. J., & Hunninghake, G. W. (2001) · New England Journal of Medicine · doi:10.1056/nejmra003200 · Cited by 962
The epidemiology of interstitial lung diseases.
Coultas, D. B., Zumwalt, R. E., Black, W. C., & Sobonya, R. E. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.4.7921471 · Cited by 946
Regulation of PDGF and its receptors in fibrotic diseases
Bonner, J. C. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.03.006 · Cited by 768
Kolb, M., Margetts, P. J., Anthony, D. C., Pitossi, F., & Gauldie, J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12568 · Cited by 753
Battegay, E. J., Raines, E. W., Seifert, R. A., Bowen-Pope, D. F., & Ross, R. (1990) · Cell · doi:10.1016/0092-8674(90)90448-n · Cited by 741
A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis
Rubin, P., Johnston, C. J., Williams, J. P., McDonald, S., & Finkelstein, J. N. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00095-g · Cited by 648
Interleukin-1 Mitogenic Activity for Fibroblasts and Smooth Muscle Cells Is Due to PDGF-AA
Raines, E. W., Dower, S. K., & Ross, R. (1989) · Science · doi:10.1126/science.2783498 · Cited by 646
Daniels, C. E., Wilkes, M. C., Edens, M., Kottom, T. J., Murphy, S. J., LIMPER, A. H., & Leof, E. B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19603 · Cited by 574
PDGF receptors as cancer drug targets
Pietras, K., Sjöblom, T., Rubin, K., Heldin, C.-H., & Östman, A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00089-8 · Cited by 465
Martinet, Y., Rom, W. N., Grotendorst, G. R., Martin, G. R., & Crystal, R. G. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707233170404 · Cited by 414
Endostatin's Antiangiogenic Signaling Network
Abdollahi, A., Hahnfeldt, P., Maercker, C., Gröne, H.-J., Debus, J., Ansorge, W., Folkman, J., Hlatky, L., & Huber, P. E. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00102-9 · Cited by 393
Self-citationPlatelet-derived growth factor in idiopathic pulmonary fibrosis.
Antoniades, H. N., Bravo, M. A., Avila, R. E., Galanopoulos, T., Neville-Golden, J., Maxwell, M., & Selman, M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114808 · Cited by 384
Movsas, B., Raffin, T. A., Epstein, A. H., & Link, C. J. (1997) · Chest · doi:10.1378/chest.111.4.1061 · Cited by 343
Pinzani, M., Milani, S., Herbst, H., DeFranco, R., Grappone, C., Gentilini, A., Caligiuri, A., Pellegrini, G., Ngo, D. V., Romanelli, R. G., et al. (1996) · Europe PMC (PubMed Central) · Cited by 286
Hodgson, U. (2002) · Thorax · doi:10.1136/thorax.57.4.338 · Cited by 249
Involvement of platelet-derived growth factor in disease: development of specific antagonists
(2001) · Advances in Cancer Research · doi:10.1016/s0065-230x(01)80010-5 · Cited by 202
Yamakage, A., Kikuchi, K., Smith, E. A., LeRoy, E. C., & Trojanowska, M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1227 · Cited by 184
Gurujeyalakshmi, G., Hollinger, M. A., & Giri, S. N. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.276.2.l311 · Cited by 179
The sequence of histological changes in mouse lungs after single doses of X-rays
Travis, E. L. (1980) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(80)90145-5 · Cited by 174
A pivotal role of cytosolic phospholipase A2 in bleomycin-induced pulmonary fibrosis
Nagase, T., Uozumi, N., Ishii, S., Kita, Y., Yamamoto, H., Ohga, E., Ouchi, Y., & Shimizu, T. (2002) · Nature Medicine · doi:10.1038/nm0502-480 · Cited by 163
Abdollahi, A., Lipson, K. E., Sckell, A., Zieher, H., Klenke, F. M., Poerschke, D., Roth, A. K., Han, X., Krix, M., Bischof, M., et al. (2003) · PubMed · Cited by 160
Self-citationGrowth factors in idiopathic pulmonary fibrosis: relative roles
Allen, J., & Spiteri, M. A. (2001) · Respiratory Research · doi:10.1186/rr162 · Cited by 160
Pontén, A., Li, X., Thorén, P., Aase, K., Sjöblom, T., Östman, A., & Eriksson, U. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63694-2 · Cited by 154
Abdollahi, A., Lipson, K. E., Han, X., Krempien, R. C., Trinh, T., Weber, K. J., Hahnfeldt, P., Hlatky, L., Debus, J., Howlett, A. R., et al. (2003) · PubMed · Cited by 149
Self-citationRice, A. B., Moomaw, C. R., Morgan, D. L., & Bonner, J. C. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65115-2 · Cited by 148
Yoshida, M., Sakuma, J., Hayashi, S., Abe, K., Saito, I., Harada, S., Sakatani, M., Yamamoto, S., Matsumoto, N., & Kaneda, Y. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9570 · Cited by 145
Hoyle, G. W., Li, J., Finkelstein, J. B., Eisenberg, T., Liu, J., Lasky, J. A., Athas, G., Morris, G. F., & Brody, A. R. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65432-6 · Cited by 131
Sharplin, J., & Franko, A. J. (1989) · Radiation Research · doi:10.2307/3577364 · Cited by 131
Pharmacological Therapy for Idiopathic Pulmonary Fibrosis: Past, Present, and Future
Mason, R. J., Schwarz, M. I., Hunninghake, G. W., & Musson, R. A. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.5.9903009 · Cited by 125
Battegay, E., Raines, E. W., Colbert, T., & Ross, R. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.11.6040 · Cited by 120
Sharplin, J., & Franko, A. J. (1989) · Radiation Research · doi:10.2307/3577363 · Cited by 109
Beljaars, L., Weert, B., Geerts, A. E., Meijer, D. K. F., & Poelstra, K. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00445-3 · Cited by 103
Maeda, A., Hiyama, K., Yamakido, H., Ishioka, S., & Yamakido, M. (1996) · CHEST Journal · doi:10.1378/chest.109.3.780 · Cited by 100
Rapid Activation of PDGF-A and -B Expression at Sites of Lung Injury in Asbestos-exposed Rats
Liu, J., Morris, G. F., Lei, W.-H., Hart, C. E., Lasky, J. A., & Brody, A. R. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.17.2.2956 · Cited by 94
Preneoplastic lesions of the lung
Greenberg, A. K., Yee, H. T., & Rom, W. N. (2002) · Respiratory Research · doi:10.1186/rr170 · Cited by 90
Hallahan, D. E. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.10.733 · Cited by 81
Computed Tomography Monitoring of Radiation-Induced Lung Fibrosis in Mice
Plathow, C., Li, M., Gong, P., Zieher, H., Kiessling, F. M., Peschke, P., Kauczor, H., Abdollahi, A., & Huber, P. E. (2004) · Investigative Radiology · doi:10.1097/01.rli.0000138134.89050.a5 · Cited by 71
Self-citationSavikko, J., Taskinen, E., & von Willebrand, E. (2003) · Transplantation · doi:10.1097/01.tp.0000062836.93496.ce · Cited by 65
Organizational response of normal tissues to irradiation
Travis, E. L. (2001) · Seminars in Radiation Oncology · doi:10.1053/srao.2001.25243 · Cited by 64
Increasing tumor uptake of anticancer drugs with imatinib
Pietras, K. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.03.036 · Cited by 61
Yamasaki, Y., Miyoshi, K., Oda, N., Watanabe, M., Miyake, H., Chan, J., Wang, X., Sun, L., Tang, C., McMahon, G., et al. (2001) · Circulation Research · doi:10.1161/01.res.88.6.630 · Cited by 54
Self-citationKamp, D. W. (2003) · CHEST Journal · doi:10.1378/chest.124.4.1187 · Cited by 43
Increased Binding and Chemotactic Capacities of PDGF-BB on Fibroblasts in Radiation Pneumonitis
Tada, H., Ogushi, F., Tani, K., Nishioka, Y., Miyata, J., Sato, K., Asano, T., & Sone, S. (2003) · Radiation Research · doi:10.1667/0033-7587(2003)159[0805:ibacco]2.0.co;2 · Cited by 23
Cain, J. A., Grisolano, J. L., Laird, A., & Tomasson, M. H. (2004) · Blood · doi:10.1182/blood-2003-11-3801 · Cited by 15
Cited by
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
Richeldi, L., Costabel, U., Selman, M., Kim, D. S., Hansell, D. M., Nicholson, A. G., Brown, K. K., Flaherty, K. R., Noble, P. W., Raghu, G., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103690 · Cited by 1,157
Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
Wollin, L., Wex, E., Pautsch, A., Schnapp, G., Hostettler, K. E., Stowasser, S., & Kolb, M. (2015) · European Respiratory Journal · doi:10.1183/09031936.00174914 · Cited by 1,005
De Ruysscher, D., Niedermann, G., Burnet, N. G., Siva, S., Lee, A. W. M., & Hegi-Johnson, F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0064-5 · Cited by 868
Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition
Force, T., Krause, D. S., & Van Etten, R. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2106 · Cited by 801
Metadata
- Authors
- Abdollahi, A., Li, M., Ping, G., Plathow, C., Domhan, S., Kiessling, F., Lee, L. B., McMahon, G., Gröne, H.-J., Lipson, K. E., & Huber, P. E.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2005-03-21
- Volume
- 201
- Issue
- 6
- Pages
- 925-935
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2112302625
- Cited by
- 388
- References
- 51
- FWCI
- 20.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.